Journal:
:iranian journal of pharmaceutical research
0
alireza mahboubian faculty of pharmacy, tehran university of medical sciences, tehran, iran.
seyyed kazem hashemein faculty of pharmacy, tehran university of medical sciences, tehran, iran.
shadi moghadam medical nanotechnology research centre, tehran university of medical sciences, tehran, iran.
fatemeh atyabi faculty of pharmacy, tehran university of medical sciences, tehran, iran. medical nanotechnology research centre, tehran university of medical sciences, tehran, iran.
rassoul dinarvand faculty of pharmacy, tehran university of medical sciences, tehran, iran. medical nanotechnology research centre, tehran university of medical sciences, tehran, iran.
triptoreline is a potent agonist of luteinizing hormone-releasing hormone, currently used in the treatment of prostatic cancer where therapy may be required over months or years. frequent injection of drug decreases patients’ compliance. the present study describes the formulation of a sustained release microparticulate drug delivery system containing triptoreline acetate, using poly (d,l lacti...